Evidence map›Paper›PMID 41611959›Full record

ReviewNature protocols2026

CellRank: consistent and data view agnostic fate mapping for single-cell genomics.

Philipp Weiler, Fabian J Theis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philipp WeilerInstitute of Computational Biology, Helmholtz Center, Munich, Germany.ORCID http://orcid.org/0000-0002-0992-7043
Fabian J TheisInstitute of Computational Biology, Helmholtz Center, Munich, Germany. fabian.theis@helmholtz-munich.de.ORCID http://orcid.org/0000-0002-2419-1943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell RNA sequencing quantifies biological samples at an unprecedented scale, allowing us to decipher biological differentiation dynamics such as normal development or disease progression. As conventional single-cell RNA sequencing experiments are destructive by nature, reconstructing cellular trajectories computationally is an essential aspect of analysis pipelines. To infer trajectories in a consistent and scalable manner, we have developed CellRank. In its first iteration, CellRank quantitatively recovered trajectories from RNA velocity estimates and transcriptomic similarity. Given these data views, CellRank constructed a cell-cell transition matrix, inducing a Markov chain to automatically infer terminal states and describe their lineage formation. However, CellRank did not enable incorporating complementary data views such as experimental time points, pseudotime or stemness potential. To facilitate these and future views, CellRank 2 generalizes CellRank's trajectory inference framework to multiview single-cell data, leading to a general and scalable framework for cellular fate mapping. Overall, the CellRank framework enables the consistent quantification of cellular fate, combining complementary views and analyzing lineage priming consistently. Here we provide detailed protocols on how to run exemplary CellRank analyses at scale and across different data views. Using CellRank requires basic apprehension and knowledge of single-cell omics data and the Python programming language.

Indexed as

GenomicsSequence Analysis, RNASingle-Cell AnalysisSoftwareAnimalsCell DifferentiationCell LineageSingle-Cell Gene Expression Analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.